Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 80 years old
- People diagnosed with a specific type of head and neck cancer (squamous cell carcinoma) that has not spread to other parts of the body, originating in areas such as the mouth, throat, voice box, or nasal passages
- People whose treatment plan includes radiation therapy or a combination of chemotherapy and radiation therapy aimed at curing the cancer (people who have already had surgery for their head and neck cancer may still be eligible)
- People who have been cleared by their medical team to do exercise
- People whose first treatment is not scheduled to start within the next 3 weeks at the time they are recruited into the study
- People who speak English or Spanish
Who may not be able to join:
- People whose cancer has spread (metastasised) to other parts of the body
- People who are unable to complete the initial assessments or begin the pre-treatment program before their radiation or chemoradiation treatment starts
- People for whom a doctor has determined that changes to diet or physical exercise would be unsafe
- People who do not speak English or Spanish
- People with a history of dementia or a major psychiatric condition that could interfere with taking part in the study
- People who have had a stroke, heart attack, or heart failure within the past year
- People whose overall physical functioning is assessed by their medical team as significantly limited (confirm with trial site regarding the specific scoring scale used)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Akina Natori, MD, MSPH, University of Miami
Phone: (305) 243-6005
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Aim 2: Feasibility of Participant Engagement in Prehabilitation Prescription Program; Aim 2: Feasibility of Participant Attendance to Scheduled Visits of the Prehabilitation Prescription Protocol; Aim 2: Acceptability of Participants That Feel Satisfied with the Prehabilitation Prescription Protocol
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.